Home   |  Publications   |   Conferences    |  Join   |   Contact   | Sitemap  
Facebook    Twitter     Linkedin     RSS    BLOG    You Tube
 

Journal of Antivirals & Antiretrovirals


Open Access
 
ISSN: 1948-5964
 
 
 
HOME » ANTIVIRALS-ANTIRETROVIRALS French Language  |  English
 
 
 
 
 
 
SCImago Journal & Country Rank
 

Upcoming Event

 

About the Journal

Editors Recommendation for Indexing
Ralph Welcome Message

Welcome to the Journal of Antivirals and Antiretrovirals (JAA): An open-access, multidisciplinary journal for the discovery and development of antiviral drugs.

I welcome you to a truly interdisciplinary journal which attracts the interest of scientists from various fields such as systems biology, chemistry, virology, and the clinical sciences.
 
The Journal of Antivirals & Antiretrovirals (JAA) paves the way to discovery and development of antiviral drugs, compounds, and clinical methods to prevent viral infections. Importantly, JAA provides the opportunity to inform researchers, clinicians, and others working in the field of antiviral drugs and therapies. JAA is an internationally recognized journal for scientists involved in basic, applied, and clinical aspects of antiviral and antiretroviral research. It is known that many viruses emerge and re-emerge threatening both animal and human populations. Zoonotic viruses can cause extensive morbidity and mortality; however, preventive vaccines that provide protection are available for only a limited number of viruses.
flyer image Impact Factor: 2.96*
Index Copernicus Value: 4.86
H-Factor: 2
 
The primary current therapeutic approach against viral diseases is to target viral components that are essential for replication. There are a number of disadvantages targeting viral components including the limited number of druggable viral targets because viruses have a small genome, as well as the rapid development of drug resistance. New drug therapies combine antivirals to increase efficacy and to avoid the development of drug resistant strains. These strategies are effective for viruses such as HIV, but clearly there is a need to expand our drug arsenal to address the wide diversity of viruses. This pathway relies on alternative strategies for drug discovery, such as examining the virus-host interface.
 
High-throughput RNA interference (RNAi) technology is a platform-enabling technology that allows for rapid searching and validation of biologically relevant target genes in the host. RNAi can be used to silence each and every gene in a host to ask what genes are needed for virus replication. Perhaps the greatest challenge is identify and validate the host genes and pathways they intersect among all the interactions relevant to virus replication. Here, antiviral drugs targeting host genes/factors can be discovered that markedly expand the number of druggable targets that can be temporarily silenced to prevent virus replication. This genome-wide exploration of virus-host interactions allows for a paradigm change in drug discovery because it provides critical host gene/pathway information allowing for drug rescue and repurposing. This systems-based approach to antiviral drug discovery integrates multiple ‘-omics’ approaches because much is learned about host genes co-opted by the virus for metabolomics, and proteins usurped for viral protein trafficking and viral packaging (proteomics), and the like. This information helps to find drugs lacking undesired side effects, and uses a rational approach in drug screening.
 
As the Editor-in-Chief of Journal of Antivirals & Antiretrovirals, I believe the strength of this open access journal is determined by the quality of manuscripts that it receives, and by the assembly of its editorial board that must encourage contributions from leading investigators. As JAA is an open-access, multidisciplinary journal for the discovery and development of antiviral drugs, it allows for rigorous review and rapid publication without unnecessary delay or expense. I expect JAA to become a venue for top-quality manuscripts and look forward to reading your contributions. Best.
 
Editor-in-Chief
Ralph A Tripp
Professor
Department of Infectious Diseases
University of Georgia
USA
Tel. 706-542-1557
 
The journal is using Editorial Tracking System for quality in review process. Editorial Tracking is an online manuscript submission, review and tracking systems. Review processing is performed by the editorial board members of Journal of Antivirals & Antiretrovirals or outside experts; at least two independent reviewers approval followed by editor approval is required for acceptance of any citable manuscript. Authors may submit manuscripts and track their progress through the system, hopefully to publication. Reviewers can download manuscripts and submit their opinions to the editor. Editors can manage the whole submission/review/revise/publish process.
 
Submit manuscript at http://www.editorialmanager.com/virology/ or send as an e-mail attachment to the Editorial Office at editor.jaa@omicsonline.org
* Unofficial 2012 Impact Factors were established by dividing the number of articles published in 2010 and 2011 were cited in 2012 based on a search of the Google Scholar Citation Index database, by the number of articles published in the previous two years (2010 and 2011).
A = the number of times, articles published in 2010 and 2011, were cited by indexed journals during 2012
B = the total number of "citable items" published by that journal in 2010 and 2011.
(Ref: http://en.wikipedia.org/wiki/Impact_factor)
 

Recently published articles

Addressing the Re-emergence of Poliovirus
Ralph A Tripp
 
Impact of Combination Interferon Therapy on the Body Weight, Body Fat and Lean Body Mass of Chronic HCV Infected Patients
Ibrar Alam, Ijaz Ali, Sajid Ali, Iftikhar Alam, Farzana and Zeeshan Naseem
 
Adherence to Highly Active Antiretroviral Therapy, in Depressed Peoples Living with HIV/AIDS in Nigeria, West Africa
Shittu RO, Issa BA, Olanrewaju GT, Odeigah LO, Sule AG, Musa A Sanni and Aderibigbe SA
 
Quantitative Transmitted Drug Resistance (TDR) Variation in Acute/Recently Infected Men who have Sex with Men (MSM) Chinese HIV Patient Cohort
Lili Dai, Supriya D Mahajan, Donald L Sykes, Bindukumar Nair, Stanley A Schwartz, Chiu-Bin Hsiao, Hao Wu and Ning Li
 
Prevalence of Transmitted HIV-1 Drug Resistance (TDR) Associated Mutations and Predicted Drug Sensitivity in Newly Diagnosed HIV-1 Patient Cohort in a Western New York, 2005-2011
Lili Dai, Supriya D Mahajan, Donald L Sykes, Alyssa Shon, Stanley A Schwartz, Ning Li, Hao Wu and Chiu-Bin Hsiao
 
Synthesis of 3, 7-Dimethyl-2, 6-Octadienal Acetals from Citral Extracted from Lemon Grass, Cymbopogon citrates L.
Phool Shahzadi, Ali Muhammad, Ferhat Mehmood and Muhammad Yasir Chaudhry
 
A New Paradigm for Developing Antiviral Drugs Exemplified by the Development of Supremely High Anti-HIV Active EFdA
Hiroshi Ohrui
 
Modeling Human Respiratory Viral Infections in the Cotton Rat (Sigmodon hispidus)
Jorge CG Blanco, Marina S Boukhvalova, Daniel R Perez, Stefanie N Vogel and Adriana Kajon
 
 
 
 
 
 
20082014 OMICS Group - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version